Colitis Trial Invites Patients to Explore Stem Cell Therapy
A new ulcerative colitis trial is inviting patients with medically refractory disease to explore an experimental stem cell approach that aims to reduce inflammation and support mucosal healing. The study is aimed at people who have already failed standard therapies and may be facing colectomy, making it a potentially important option for a very hard-to-treat group.